Annual ROE
-289.17%
-164.30%-131.58%
31 December 2023
Summary:
Spyre Therapeutics annual return on equity is currently -289.17%, with the most recent change of -164.30% (-131.58%) on 31 December 2023. During the last 3 years, it has fallen by -230.36% (-391.70%). SYRE annual ROE is now -560.21% below its all-time high of -43.80%, reached on 01 December 2016.SYRE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-82.81%
+77.08%+48.21%
30 September 2024
Summary:
Spyre Therapeutics quarterly return on equity is currently -82.81%, with the most recent change of +77.08% (+48.21%) on 30 September 2024. Over the past year, it has dropped by -402.14% (-125.93%). SYRE quarterly ROE is now -106.62% below its all-time high of 1250.71%, reached on 31 March 2024.SYRE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -131.6% | -125.9% |
| 3 y3 years | -391.7% | -43.1% |
| 5 y5 years | -135.6% | +10.4% |
SYRE ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -391.7% | at low | -106.6% | +98.3% |
| 5 y | 5 years | -391.7% | at low | -106.6% | +98.3% |
| alltime | all time | -560.2% | +47.7% | -106.6% | +98.3% |
Spyre Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -82.81%(-48.2%) |
| June 2024 | - | -159.89%(-112.8%) |
| Mar 2024 | - | 1250.71%(+117.0%) |
| Dec 2023 | -289.17%(+131.6%) | 576.41%(+80.5%) |
| Sept 2023 | - | 319.33%(-106.6%) |
| June 2023 | - | -4815.53%(+3580.8%) |
| Mar 2023 | - | -130.83%(+8.5%) |
| Dec 2022 | -124.87%(+112.3%) | - |
| Dec 2022 | - | -120.56%(+12.7%) |
| Sept 2022 | - | -106.96%(+10.2%) |
| June 2022 | - | -97.05%(+32.2%) |
| Mar 2022 | - | -73.42%(+26.9%) |
| Dec 2021 | -58.81%(-27.3%) | -57.86%(+5.6%) |
| Sept 2021 | - | -54.81%(+11.8%) |
| June 2021 | - | -49.02%(-27.4%) |
| Mar 2021 | - | -67.56%(-11.3%) |
| Dec 2020 | -80.93%(-34.1%) | -76.13%(-9.9%) |
| Sept 2020 | - | -84.54%(-11.7%) |
| June 2020 | - | -95.75%(-4.4%) |
| Mar 2020 | - | -100.12%(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -122.74%(+63.0%) | -92.45%(+10.1%) |
| Sept 2019 | - | -83.95%(+13.9%) |
| June 2019 | - | -73.73%(+0.7%) |
| Mar 2019 | - | -73.19%(-1.4%) |
| Dec 2018 | -75.32%(+56.7%) | -74.21%(+18.5%) |
| Sept 2018 | - | -62.62%(+12.2%) |
| June 2018 | - | -55.79%(+3.3%) |
| Mar 2018 | - | -53.99%(+14.4%) |
| Dec 2017 | -48.08%(+9.8%) | -47.19%(+10.2%) |
| Sept 2017 | - | -42.81%(+13.1%) |
| June 2017 | - | -37.86%(-4.9%) |
| Mar 2017 | - | -39.80%(+0.1%) |
| Dec 2016 | -43.80%(-26.4%) | -39.76%(-1.8%) |
| Sept 2016 | - | -40.47%(+4.5%) |
| June 2016 | - | -38.74%(+12.1%) |
| Mar 2016 | - | -34.56%(+23.7%) |
| Dec 2015 | -59.48%(-89.2%) | -27.93%(-15.1%) |
| Sept 2015 | - | -32.89%(-6.7%) |
| June 2015 | - | -35.24%(-29.8%) |
| Mar 2015 | - | -50.21%(-90.9%) |
| Dec 2014 | -552.72% | -552.72% |
FAQ
- What is Spyre Therapeutics annual return on equity?
- What is the all time high annual ROE for Spyre Therapeutics?
- What is Spyre Therapeutics annual ROE year-on-year change?
- What is Spyre Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly ROE year-on-year change?
What is Spyre Therapeutics annual return on equity?
The current annual ROE of SYRE is -289.17%
What is the all time high annual ROE for Spyre Therapeutics?
Spyre Therapeutics all-time high annual return on equity is -43.80%
What is Spyre Therapeutics annual ROE year-on-year change?
Over the past year, SYRE annual return on equity has changed by -164.30% (-131.58%)
What is Spyre Therapeutics quarterly return on equity?
The current quarterly ROE of SYRE is -82.81%
What is the all time high quarterly ROE for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly return on equity is 1250.71%
What is Spyre Therapeutics quarterly ROE year-on-year change?
Over the past year, SYRE quarterly return on equity has changed by -402.14% (-125.93%)